Next Article in Journal
The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy
Previous Article in Journal
Wiara czyni cuda—Środkowo-Wschodnioeuropejska Sieć Alfa-1 Antytrypsyny
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of COPD Progression Based on Spirometry and Exercise Capacity

by
Marzena Trzaska-Sobczak
1,*,
Grzegorz Brożek
2,
Małgorzata Farnik
1 and
Władysław Pierzchała
1
1
Department and Clinic of Pulmonology, Medical University of Silesia in Katowice, ul. Medyków 14, 40-752 Katowice, Poland
2
Department and Unit of Epidemiology, Medical University of Silesia in Katowice, 40-752 Katowice, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2013, 81(4), 288-293; https://doi.org/10.5603/ARM.34786
Submission received: 14 September 2012 / Revised: 7 June 2013 / Accepted: 7 June 2013 / Published: 7 June 2013

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by an airflow limitation that is usually progressive. The progression of COPD expressed as the rate of an annual decline in FEV1 is very heterogeneous. Exercise capacity in COPD patients is often diminished and becomes worsened over the time. The purpose of the study was to examine how the change in FEV1 and exercise capacity would deteriorate over long-term observation. Material and Methods: A total of 22 men with COPD were examined. At the beginning the average age was 59 ± 8.1 years and the mean post-bronchodilator FEV1 was 52 ± 14.9% predicted. Pulmonary function testing was performed at entry and then each year for 10 years, and exercise testing on a cycle ergometer was performed at entry and after 10 years. Results: FEV1 and maximum oxygen uptake (VO2max), maximum mechanical work (Wmax), maximum minute ventilation (VEmax) and maximum tidal volume (VTmax) declined significantly over the observation time. The mean annual decline in FEV1 was 42 ± 37 mL, and the mean decline for VO 2max was 30 ± 15 mL/min/yr and 0.44 ± 0.25 mL/min/kg/yr. Regression analysis revealed that the changes in FEV1 do not predict changes in VO2max. We observed a correlation between the annual change in VEmax and annual change in VO2max (r = 0.51; p < 0.05). The baseline FEV1 (expressed as a percentage of predicted and in absolute values) is the predictor of FEV1 annual decline (r = 0.74 and 0.82; p < 0.05). Conclusions: We observed over time deterioration in exercise capacity in COPD patients which is independent of decline in airflow limitation. The long term follow-up of exercise capacity is important in monitoring of COPD patients in addition to pulmonary function.
Keywords: COPD; exercise capacity; COPD progression; annual FEV1 decline COPD; exercise capacity; COPD progression; annual FEV1 decline

Share and Cite

MDPI and ACS Style

Trzaska-Sobczak, M.; Brożek, G.; Farnik, M.; Pierzchała, W. Evaluation of COPD Progression Based on Spirometry and Exercise Capacity. Adv. Respir. Med. 2013, 81, 288-293. https://doi.org/10.5603/ARM.34786

AMA Style

Trzaska-Sobczak M, Brożek G, Farnik M, Pierzchała W. Evaluation of COPD Progression Based on Spirometry and Exercise Capacity. Advances in Respiratory Medicine. 2013; 81(4):288-293. https://doi.org/10.5603/ARM.34786

Chicago/Turabian Style

Trzaska-Sobczak, Marzena, Grzegorz Brożek, Małgorzata Farnik, and Władysław Pierzchała. 2013. "Evaluation of COPD Progression Based on Spirometry and Exercise Capacity" Advances in Respiratory Medicine 81, no. 4: 288-293. https://doi.org/10.5603/ARM.34786

Article Metrics

Back to TopTop